Ann: Imugene AGM Presentation, page-108

  1. 6,522 Posts.
    lightbulb Created with Sketch. 2055
    Here's a comment from me ....

    1. Clearly the mood on this thread ( save for a couple of posters earlier ) is that what IMU have is
    maybe ....." not that great "
    and no one is likely to be interested in their IP ( Thanks for your interpretation Steins .... resident molecular biologist / oncologist )

    2. Great to vent ...and so many think a CR is on the ...... which if is ...would most likely knock the share price around .

    3. That being so .... why would people still hold ???? out of some perverse pessimistic optimism I suppose

    4. Very disappointing that the directors didn't share confidential and potentially market sensitive information
    with shareholders at the AGM - poor show I reckon ...and the moaners are entitled to be upset .

    5. Perhaps its time for everyone to let go ......

    Ahh dear ..... personally I would like that ...... it would be like the old days where there was a
    good and reasonable input from a lot of contributors .


    so dump away , get in before the rush and be very comfortable with your choice
    and personally I couldn't give a rats arse

    Its a stock you will all remember for various reasons

    Feel free to comment ......

    https://www.imugene.com/


    LOL

    Have a great day all and for those people with vision keep reading / researching
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.2¢
Change
-0.001(7.69%)
Mkt cap ! $89.60M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $140.7K 11.61M

Buyers (Bids)

No. Vol. Price($)
50 9000852 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 6923007 25
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.